McKesson Applauds DOJ Policy Change on Opioid Quotas

McKesson Corporation today praised the U.S. Department of Justice’s decision
to exercise its authority to reduce opioid production if the agency
believes a particular drug is highly diverted.

“We applaud this common-sense action by the Department of Justice. The
annual opioid production quota determines the total amount of controlled
substances that can be produced each year. That authority is significant
as the nation struggles to address the current public health crisis
around opioid addiction. This new rule calls on the Drug Enforcement
Administration to carefully assess which drugs are being diverted – an
important part of the effort to curb opioid misuse and abuse.”

In October
2017, McKesson called on the DEA to revise its annual production quota
for opioids.

McKesson is deeply concerned by the impact the opioid epidemic is having
on families and communities across the nation—and is committed to being
part of the solution. The company has formed an independent foundation
dedicated to addressing the crisis, to which McKesson contributed $100
million. The company is also advancing company
initiatives aimed at preventing opioid abuse and has
offered thoughtful public
policy recommendations, including the Prescription
Safety-Alert System (RxSAS) technology proposal.

To learn more about McKesson’s comprehensive efforts to address the
opioid epidemic, please visit:

About McKesson Corporation

McKesson Corporation, currently ranked 5th on the FORTUNE
500, is a global leader in healthcare supply chain management solutions,
retail pharmacy, community oncology and specialty care, and healthcare
information technology. McKesson partners with pharmaceutical
manufacturers, providers, pharmacies, governments and other
organizations in healthcare to help make the right medicines, medical
products and healthcare services available to the right patients at the
right time, safely and cost-effectively. United by our ICARE shared
principles, our employees work every day to innovate and deliver
opportunities that make our customers and partners more successful — all
for the better health of patients. McKesson has been named the “Most
Admired Company” in the healthcare wholesaler category by FORTUNE, a
Place to Work” by the Human Rights Campaign Foundation, and a top military-friendly
company by Military Friendly. For more information, visit

View source version on

Leave a Comment